Clinical Infectious Diseases has launched a new series that will provide an in-depth look at real-life complex cases and the ...

In recent months, the Trump administration’s decisive action to roll back diversity, equity, and inclusion initiatives has ...

The use of AI in healthcare is experiencing a boon in both drug discovery (a topic for another column) and medical devices.

ST-001, an intravenous nanoformulation of fenretinide, will be evaluated in a phase 1a/1b small cell lung cancer trial.

Q1 2025 Earnings Call Transcript April 15, 2025 Johnson & Johnson beats earnings expectations. Reported EPS is $2.77, ...

Building on the success of the inaugural edition, '"The Evolution in Pharmacology of Infectious Diseases ... and support contributing authors. In some cases, they can also be assigned as reviewers.

As thousands of people await a lifesaving heart, scientists are racing to buy them more time. A promising advance from scientists in Germany offers a potential solution.

Triple-negative breast cancer, an aggressive type of breast cancer, accounts for 10% of all breast cancer cases in the United States annually. CD8+ T cells that normally kill cancer cells often become ...

A new study led by scientists at NYU Langone Health sheds light on how the major cancer gene BRCA2 determines which cancer cells can be killed by a class of precision cancer drugs called PARP ...

Oxidative stress is a fundamental concern in the field of biomedical research, resulting from an imbalance between reactive oxygen species (ROS) production ...

India’s move toward medical education in regional languages aims to boost accessibility. Experts, however, warn of challenges ...

Catching HBV early can make a world of difference. Medical professionals typically use blood tests that check for signs of the virus in the body, such as HBV antigens or antibodies. They also ...